Akzo Nobel N.V.
AKZOF
$68.00
-$0.48-0.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.09% | 1.52% | -0.54% | -4.05% | 2.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.09% | 1.52% | -0.54% | -4.05% | 2.54% |
| Cost of Revenue | -1.56% | 1.98% | 1.91% | -2.31% | 4.80% |
| Gross Profit | -0.37% | 0.84% | -4.07% | -6.54% | -0.79% |
| SG&A Expenses | -3.07% | 1.50% | -0.29% | 0.37% | 6.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -72,391.87% | 5,706.33% | -110.90% | -3.07% | 104.72% |
| Total Operating Expenses | -30.73% | 13.69% | 1.11% | -1.39% | 6.70% |
| Operating Income | 552.77% | -108.40% | -15.49% | -27.66% | -40.68% |
| Income Before Tax | 757.55% | -141.33% | -22.65% | -34.99% | -5.94% |
| Income Tax Expenses | 159.13% | 29.82% | -12.46% | -18.37% | 19.22% |
| Earnings from Continuing Operations | 1,738.29% | -218.85% | -25.47% | -39.85% | -30.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.76% | 54.42% | 22.67% | -4.39% | -112.17% |
| Net Income | 3,009.76% | -226.57% | -26.13% | -42.69% | -49.29% |
| EBIT | 552.77% | -108.40% | -15.49% | -27.66% | -40.68% |
| EBITDA | 329.61% | -78.56% | -10.27% | -20.17% | -28.65% |
| EPS Basic | 3,003.43% | -226.42% | -26.26% | -42.76% | -49.32% |
| Normalized Basic EPS | 989.15% | -142.89% | -22.78% | -38.61% | -43.19% |
| EPS Diluted | 3,027.76% | -227.14% | -26.71% | -43.30% | -49.86% |
| Normalized Diluted EPS | 1,011.00% | -143.08% | -22.74% | -39.19% | -44.47% |
| Average Basic Shares Outstanding | 0.18% | 0.12% | 0.18% | 0.12% | 0.12% |
| Average Diluted Shares Outstanding | -1.81% | -0.34% | 0.12% | 1.07% | 2.44% |
| Dividend Per Share | 9.20% | -- | 5.45% | -- | -0.98% |
| Payout Ratio | -0.98% | -5.54% | 0.41% | 0.27% | 0.85% |